BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 110797
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110797
Figure 1
Figure 1 Flowchart of the study. MAFLD: Metabolic dysfunction-associated fatty liver disease; T2DM: Type 2 diabetes mellitus.
Figure 2
Figure 2 Prevalence of metabolic dysfunction-associated fatty liver disease by different age, sex, and body mass index. A: The prevalence of MAFLD according to different age and gender; B: The prevalence of MAFLD according to different BMI and gender. BMI: Body mass index; MAFLD: Metabolic dysfunction-associated fatty liver disease.